Ecor1 Capital, Llc Portfolio Stock Holdings
Ecor1 Capital, Llc disclosed 29 stock positions valued at approximately $2.3 billion in its latest SEC 13F filing. The largest holdings include ZYMEWORKS INC, ANAPTYSBIO INC, and CENTESSA PHARMACEUTICALS PLC. The filing reflects positions held as of March 31, 2026 and was filed on May 15, 2026.
- Report Period
- March 31, 2026
- No. of Stocks
- 29
- Portfolio Value
- $2.3B
Holdings by Sector
Ecor1 Capital, Llc Portfolio Holdings in Q1 2026
20 holdings in the latest reporting period.
Page 1 of 1
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| ZYMEWORKS INC | ZYME | Healthcare | 24.58% | 22,970,388 | - | - | $575,178,516 |
| ANAPTYSBIO INC | ANAB | Healthcare | 18.68% | 7,880,094 | - | - | $437,030,013 |
| CENTESSA PHARMACEUTICALS PLC | CNTA | Healthcare | 10.18% | 6,000,000 | +2,885,000 | +92.62% | $238,320,000 |
| CRINETICS PHARMACEUTICALS IN | CRNX | Healthcare | 6.66% | 4,288,120 | - | - | $155,744,518 |
| ORIC PHARMACEUTICALS INC | ORIC | Healthcare | 3.64% | 6,728,116 | - | - | $85,245,230 |
| CG ONCOLOGY INC | CGON | Healthcare | 3.19% | 1,102,000 | +330,000 | +42.75% | $74,583,360 |
| ETON PHARMACEUTICALS INC | ETON | Healthcare | 2.29% | 2,171,938 | +141,394 | +6.96% | $53,603,430 |
| GALAPAGOS NV | GLPG | Healthcare | 2.14% | 1,667,119 | - | - | $50,013,570 |
| XENCOR INC | XNCR | Healthcare | 1.13% | 2,183,000 | -1,068,112 | -32.85% | $26,326,980 |
| NEUROGENE INC | NGNE | Healthcare | 1.10% | 1,271,342 | - | - | $25,630,255 |
| RELAY THERAPEUTICS INC | RLAY | Healthcare | 0.81% | 1,904,762 | +1,904,762 | +100.00% | $18,952,382 |
| ERASCA INC | ERAS | Healthcare | 0.62% | 900,000 | +900,000 | +100.00% | $14,562,000 |
| REPLIMUNE GROUP INC | REPL | Healthcare | 0.33% | 1,000,000 | +1,000,000 | +100.00% | $7,650,000 |
| PHATHOM PHARMACEUTICALS INC | PHAT | Healthcare | 0.30% | 625,000 | +625,000 | +100.00% | $6,943,750 |
| MEREO BIOPHARMA GROUP PLC | MREO | Healthcare | 0.19% | 13,368,855 | +5,512,389 | +70.16% | $4,411,722 |
| STOKE THERAPEUTICS INC | STOK | Healthcare | 0.14% | 100,000 | +100,000 | +100.00% | $3,256,000 |
| PRELUDE THERAPEUTICS INC | PRLD | Healthcare | 0.14% | 947,049 | +947,049 | +100.00% | $3,238,908 |
| IBIO INC | IBIO | Healthcare | 0.13% | 1,583,000 | -645,000 | -28.95% | $3,007,700 |
| ATARA BIOTHERAPEUTICS INC | ATRA | Healthcare | 0.02% | 99,593 | -473,590 | -82.62% | $471,075 |
| SURROZEN INC | SRZNW | Healthcare | 0.01% | 4,444 | - | - | $129,454 |
Ecor1 Capital, Llc Options Holdings in Q1 2026
1 options positions in the latest reporting period.
Page 1 of 1
| Quarter | Symbol | Company | Option | Contracts | Notional Value |
|---|---|---|---|---|---|
| Q1 2026 | CNTA | Centessa Pharmaceuticals plc | CALL | 410,800 | $16,316,976 |
Notional value represents the total exposure of the options position.